- Home
- Publications
- Publication Search
- Publication Details
Title
FOXA1 inhibits prostate cancer neuroendocrine differentiation
Authors
Keywords
-
Journal
ONCOGENE
Volume 36, Issue 28, Pages 4072-4080
Publisher
Springer Nature
Online
2017-03-21
DOI
10.1038/onc.2017.50
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SRRM4 Drives Neuroendocrine Transdifferentiation of Prostate Adenocarcinoma Under Androgen Receptor Pathway Inhibition
- (2017) Yinan Li et al. EUROPEAN UROLOGY
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
- (2016) Himisha Beltran et al. NATURE MEDICINE
- Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome
- (2015) S C Wightman et al. BRITISH JOURNAL OF CANCER
- SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer
- (2015) X. Zhang et al. CLINICAL CANCER RESEARCH
- The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer
- (2015) Shusuke Akamatsu et al. Cell Reports
- Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancer
- (2015) Dong Lin et al. Oncotarget
- Concurrent AURKA and MYCN Gene Amplifications Are Harbingers of Lethal TreatmentRelated Neuroendocrine Prostate Cancer
- (2015) Juan Miguel Mosquera et al. NEOPLASIA
- FOXA1 deletion in luminal epithelium causes prostatic hyperplasia and alteration of differentiated phenotype
- (2014) David J DeGraff et al. LABORATORY INVESTIGATION
- The Many Faces of Neuroendocrine Differentiation in Prostate Cancer Progression
- (2014) Stéphane Terry et al. Frontiers in Oncology
- Neuroendocrine differentiation of prostate cancer
- (2013) Zhen Li et al. ASIAN JOURNAL OF ANDROLOGY
- Androgen Receptor-Independent Function of FoxA1 in Prostate Cancer Metastasis
- (2013) H.-J. Jin et al. CANCER RESEARCH
- Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer
- (2013) A. M. Aparicio et al. CLINICAL CANCER RESEARCH
- Expression and Function of the Progesterone Receptor in Human Prostate Stroma Provide Novel Insights to Cell Proliferation Control
- (2013) Yue Yu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer
- (2013) Changmeng Cai et al. JOURNAL OF CLINICAL INVESTIGATION
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Discovery of a Novel ERK Inhibitor with Activity in Models of Acquired Resistance to BRAF and MEK Inhibitors
- (2013) E. J. Morris et al. Cancer Discovery
- Pathogenesis of prostatic small cell carcinoma involves the inactivation of the P53 pathway
- (2012) Hongbing Chen et al. ENDOCRINE-RELATED CANCER
- Challenges in Recognizing Treatment-Related Neuroendocrine Prostate Cancer
- (2012) Himisha Beltran et al. JOURNAL OF CLINICAL ONCOLOGY
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Prognostic Significance of Neuroendocrine Differentiation in Prostate Adenocarcinoma
- (2011) Levent Sagnak et al. Clinical Genitourinary Cancer
- Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer
- (2011) Biswajyoti Sahu et al. EMBO JOURNAL
- Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA
- (2011) Dong Wang et al. NATURE
- Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization
- (2011) Manav Korpal et al. NATURE MEDICINE
- Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
- (2011) H. Beltran et al. Cancer Discovery
- An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression
- (2010) Jindan Yu et al. CANCER CELL
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- Loss of FOXA1/2 Is Essential for the Epithelial-to-Mesenchymal Transition in Pancreatic Cancer
- (2010) Y. Song et al. CANCER RESEARCH
- FOXA1 is an essential determinant of ER expression and mammary ductal morphogenesis
- (2010) G. M. Bernardo et al. DEVELOPMENT
- Optimizing molecular signatures for predicting prostate cancer recurrence
- (2009) Yijun Sun et al. PROSTATE
- Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men
- (2008) T. A. Wallace et al. CANCER RESEARCH
- FoxA1 Translates Epigenetic Signatures into Enhancer-Driven Lineage-Specific Transcription
- (2008) Mathieu Lupien et al. CELL
- Dynamic regulation of Pdx1 enhancers by Foxa1 and Foxa2 is essential for pancreas development
- (2008) N. Gao et al. GENES & DEVELOPMENT
- Chemotherapy-Induced CXC-Chemokine/CXC-Chemokine Receptor Signaling in Metastatic Prostate Cancer Cells Confers Resistance to Oxaliplatin through Potentiation of Nuclear Factor- B Transcription and Evasion of Apoptosis
- (2008) C. Wilson et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started